Exploring co-infection dynamics and immune response interactions between COVID-19 and Monkeypox: implications for disease severity, viral transmission, and vaccine efficacy.
Oluwatoyin Ayo-Farai, Nenrot Gopep, Aminat Alarape-Raji, Huda Adnan, Maryam Ahmed, Rida Arif, Eisha Kashif, Malik Olatunde Oduoye, Muhammad Usman Haider
{"title":"Exploring co-infection dynamics and immune response interactions between COVID-19 and Monkeypox: implications for disease severity, viral transmission, and vaccine efficacy.","authors":"Oluwatoyin Ayo-Farai, Nenrot Gopep, Aminat Alarape-Raji, Huda Adnan, Maryam Ahmed, Rida Arif, Eisha Kashif, Malik Olatunde Oduoye, Muhammad Usman Haider","doi":"10.1186/s12985-025-02857-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Coronavirus disease (COVID-19) and Monkeypox (Mpox) are viral infections that have similar modes of presentation, diagnosis and treatment strategies. Understanding their co-infection dynamics and immune response is important for public health policies.</p><p><strong>Aim: </strong>This article aims to determine the relationship between dynamicity and immune response interactions between Mpox and COVID-19, focusing more on the implications for disease severity, viral transmission, and vaccine efficacy.</p><p><strong>Methodology: </strong>An extensive literature review was conducted through electronic databases including PubMed, Google Scholar and Web of Science from the last decade (2014-2024) using keywords: COVID-19, Co-infections, Immune response, Monkeypox, and Vaccination.</p><p><strong>Results: </strong>Several co-infections between COVID-19 and Mpox have been reported, especially a case from Florida, in the United States of America (USA), in Barcelona, Spain (a 56-year-old man who suffered both Mpox and COVID-19 and syphilis simultaneously, and from Italy (a 36-year-old male). Both COVID-19 and Mpox have been shown to have some effects on the immunity of a person, especially the innate system, which can occasionally produce inadvertent effects. A common factor that links the two diseases is the endoglycosidase named Heparanase (HPSE). Both COVID-19 and Mpox clinical features have bizarre severity and complications. The rising co-infection of COVID-19 and increased Mpox infection rate has led to the development of only approved vaccines JYNNEOS and COH04S1.</p><p><strong>Conclusion: </strong>Global efforts such as adequate awareness campaigns through webinars, social media platforms, and research, including experimental studies, cohort studies, case series, etc., should be put in place to give more insights into both diseases. Such efforts should be backed up with good political will, adequate funding, the establishment of research facilities and interprofessional measures among the concerned countries and policymakers in the world.</p>","PeriodicalId":23616,"journal":{"name":"Virology Journal","volume":"22 1","pages":"230"},"PeriodicalIF":4.0000,"publicationDate":"2025-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12239392/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Virology Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12985-025-02857-w","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"VIROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Coronavirus disease (COVID-19) and Monkeypox (Mpox) are viral infections that have similar modes of presentation, diagnosis and treatment strategies. Understanding their co-infection dynamics and immune response is important for public health policies.
Aim: This article aims to determine the relationship between dynamicity and immune response interactions between Mpox and COVID-19, focusing more on the implications for disease severity, viral transmission, and vaccine efficacy.
Methodology: An extensive literature review was conducted through electronic databases including PubMed, Google Scholar and Web of Science from the last decade (2014-2024) using keywords: COVID-19, Co-infections, Immune response, Monkeypox, and Vaccination.
Results: Several co-infections between COVID-19 and Mpox have been reported, especially a case from Florida, in the United States of America (USA), in Barcelona, Spain (a 56-year-old man who suffered both Mpox and COVID-19 and syphilis simultaneously, and from Italy (a 36-year-old male). Both COVID-19 and Mpox have been shown to have some effects on the immunity of a person, especially the innate system, which can occasionally produce inadvertent effects. A common factor that links the two diseases is the endoglycosidase named Heparanase (HPSE). Both COVID-19 and Mpox clinical features have bizarre severity and complications. The rising co-infection of COVID-19 and increased Mpox infection rate has led to the development of only approved vaccines JYNNEOS and COH04S1.
Conclusion: Global efforts such as adequate awareness campaigns through webinars, social media platforms, and research, including experimental studies, cohort studies, case series, etc., should be put in place to give more insights into both diseases. Such efforts should be backed up with good political will, adequate funding, the establishment of research facilities and interprofessional measures among the concerned countries and policymakers in the world.
背景:冠状病毒病(COVID-19)和猴痘(Mpox)是具有相似表现模式、诊断和治疗策略的病毒性感染。了解它们的共同感染动态和免疫反应对公共卫生政策很重要。目的:本文旨在确定Mpox与COVID-19之间的动态和免疫反应相互作用之间的关系,更多地关注对疾病严重程度、病毒传播和疫苗有效性的影响。方法:通过PubMed、谷歌Scholar和Web of Science等电子数据库对过去十年(2014-2024)的大量文献进行综述,关键词:COVID-19、合并感染、免疫反应、猴痘和疫苗接种。结果:已报告了几例COVID-19和m痘合并感染,特别是美国佛罗里达州、西班牙巴塞罗那(56岁男性,同时感染m痘、COVID-19和梅毒)和意大利(36岁男性)的1例。已证明COVID-19和Mpox都对人的免疫有一定影响,特别是先天系统,偶尔会产生无意的影响。将这两种疾病联系起来的一个共同因素是名为肝素酶(HPSE)的内糖苷酶。COVID-19和m痘的临床特征都有奇怪的严重程度和并发症。COVID-19合并感染的增加和Mpox感染率的增加导致了仅批准的疫苗JYNNEOS和COH04S1的开发。结论:应该通过网络研讨会、社交媒体平台和研究(包括实验研究、队列研究、病例系列研究等)开展充分的宣传活动等全球努力,以便对这两种疾病有更多的了解。这种努力应得到良好的政治意愿、充足的资金、建立研究设施和世界上有关国家和决策者之间的专业间措施的支持。
期刊介绍:
Virology Journal is an open access, peer reviewed journal that considers articles on all aspects of virology, including research on the viruses of animals, plants and microbes. The journal welcomes basic research as well as pre-clinical and clinical studies of novel diagnostic tools, vaccines and anti-viral therapies.
The Editorial policy of Virology Journal is to publish all research which is assessed by peer reviewers to be a coherent and sound addition to the scientific literature, and puts less emphasis on interest levels or perceived impact.